Literature DB >> 2974429

Ovarian hyperstimulation syndrome following D-Trp-6 luteinizing hormone-releasing hormone microcapsules and menotropin for in vitro fertilization.

A Golan1, R Ron-El, A Herman, Z Weinraub, Y Soffer, E Caspi.   

Abstract

In 143 cycles of in vitro fertilization the ovarian hyperstimulation syndrome (OHSS) occurred in 12 (8.4%) cycles. Six were in the moderate form and 6 severe. Ovarian stimulation by menotropins was preceded by induction of hypopituitary hypogonadism using D-Trp6-LH-RH microcapsules. The OHSS cycles are characterized by improved ovarian response expressed by the increased serum levels of estradiol, number of follicles, oocytes, embryos and pregnancy rate as compared to cycles with no OHSS. All patients recovered uneventfully. The follicular puncture did not have the suggested protective effect against OHSS. It is suggested that the substantial incidence of OHSS is probably related to the excessive ovarian stimulation not interrupted by early luteinization which is practically abolished by this protocol. The role of the given luteal hCG doses in the genesis of OHSS is questioned.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974429     DOI: 10.1016/s0015-0282(16)60371-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

1.  Ovarian hyperstimulation.

Authors:  M S Mills; P G Wardle
Journal:  BMJ       Date:  1991-02-23

Review 2.  The pathogenesis of ovarian hyperstimulation syndrome: a continuing enigma.

Authors:  A Simon; A Revel; A Hurwitz; N Laufer
Journal:  J Assist Reprod Genet       Date:  1998-04       Impact factor: 3.412

3.  In vitro fertilization programmed for weekday-only oocyte harvest: analysis of outcome based on actual retrieval day.

Authors:  A Ben-Chetrit; S Senoz; E M Greenblatt
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

4.  Outcome of frozen embryo replacement cycles following elective cryopreservation of all embryos in women at risk of developing ovarian hyperstimulation syndrome.

Authors:  A O Awonuga; N Dean; J Zaidi; R U Pittrof; J S Bekir; S L Tan
Journal:  J Assist Reprod Genet       Date:  1996-04       Impact factor: 3.412

5.  Early timed follicular aspiration prevents severe ovarian hyperstimulation syndrome.

Authors:  T Tomazevic; H Meden-Vrtovec
Journal:  J Assist Reprod Genet       Date:  1996-04       Impact factor: 3.412

6.  Follicular aspiration does not protect against the development of ovarian hyperstimulation syndrome.

Authors:  M A Aboulghar; R T Mansour; G I Serour; I Elattar; Y Amin
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

7.  Serum and follicular fluid (FF) estradiol (E2) levels in ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) conception cycles after pituitary suppression.

Authors:  J Leya; M W Molo; D Olson; E Radwanska
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-06

8.  Use of buserelin and low-dose human menopausal gonadotropin for in vitro fertilization in women at risk of ovarian hyperstimulation syndrome.

Authors:  I Wada; P L Matson; S A Troup; B A Lieberman
Journal:  J Assist Reprod Genet       Date:  1995-04       Impact factor: 3.412

9.  Severe ovarian hyperstimulation syndrome in a 42-year-old woman with successful pregnancy after intracytoplasmic sperm injection embryo transfer.

Authors:  Hiroaki Shibahara; Kazuhiko Shimada; Yukako Morimatsu; Kumiko Kikuchi; Yuki Hirano; Tatsuya Suzuki; Satoru Takamizawa; Mitsuaki Suzuki
Journal:  Reprod Med Biol       Date:  2005-11-02

10.  In vitro fertilization (IVF): a review of 3 decades of clinical innovation and technological advancement.

Authors:  Jeff Wang; Mark V Sauer
Journal:  Ther Clin Risk Manag       Date:  2006-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.